STAAR Surgical Company Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 3, 2026	Jan '26 Jan 2, 2026	Dec '24 Dec 27, 2024	Dec '23 Dec 29, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 31, 2021
Revenue	290.38	239.44	313.9	322.42	284.39	230.47
Revenue Growth (YoY)	4.03%	-23.72%	-2.64%	13.37%	23.39%	41.00%
Cost of Revenue	67.1	57.02	74.32	69.76	61.01	51.84
Gross Profit	223.27	182.42	239.58	252.65	223.38	178.64
Selling, General & Admin	239.32	188.31	206.88	184.08	143.6	111.44
Research & Development	38.64	40.06	45.32	40.48	35.98	33.86
Other Operating Expenses	8.65	45.77	-	-	-	-
Total Operating Expenses	286.61	274.13	252.19	224.55	179.58	145.3
Operating Income	-26.33	-91.71	-12.61	28.1	43.8	33.34
Interest Income	4.14	4.59	6.42	7.06	3.25	0.98
Other Non-Operating Income (Expense)	2.64	4.86	-2.86	-1.46	-1.5	-3.01
Total Non-Operating Income (Expense)	6.77	9.45	3.56	5.6	1.75	-2.04
Pretax Income	-19.56	-82.26	-9.05	33.7	45.55	31.3
Provision for Income Taxes	1.47	-1.82	11.16	12.35	5.89	3.79
Net Income	-21.03	-80.45	-20.21	21.35	39.67	27.51
Net Income to Common	-21.03	-80.45	-20.21	21.35	39.67	27.51
Net Income Growth	-	-	-	-46.18%	44.18%	365.26%
Shares Outstanding (Basic)	50	50	49	49	48	47
Shares Outstanding (Diluted)	50	50	49	49	49	49
Shares Change (YoY)	1.30%	0.90%	-0.61%	0.10%	-0.15%	3.13%
EPS (Basic)	-0.43	-1.62	-0.41	0.44	0.83	0.58
EPS (Diluted)	-0.43	-1.62	-0.41	0.43	0.80	0.56
EPS Growth	-	-	-	-46.25%	42.86%	366.67%
Free Cash Flow	-54.99	-40.05	-7.67	-3.59	17.61	30.32
Free Cash Flow Growth	-	-	-	-	-41.92%	141.63%
Free Cash Flow Per Share	-1.10	-0.81	-0.16	-0.07	0.36	0.61
Gross Margin	76.89%	76.19%	76.32%	78.36%	78.55%	77.51%
Operating Margin	-9.07%	-38.30%	-4.02%	8.71%	15.40%	14.47%
Profit Margin	-7.24%	-33.60%	-6.44%	6.62%	13.95%	11.94%
FCF Margin	-18.94%	-16.73%	-2.44%	-1.11%	6.19%	13.15%
EBITDA	-18.24	-82.99	-5.72	33.22	48.31	36.98
EBITDA Margin	-6.28%	-34.66%	-1.82%	10.30%	16.99%	16.05%
EBIT	-26.33	-91.71	-12.61	28.1	43.8	33.34
EBIT Margin	-9.07%	-38.30%	-4.02%	8.71%	15.40%	14.47%
Effective Tax Rate	-7.53%	2.21%	-123.24%	36.65%	12.92%	12.12%

SEC Filings: 10-K · 10-Q